Metformin in patients with hepatocellular carcinoma receiving immunotherapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepatology 2023-05, Vol.78 (5), p.e180-e182
Hauptverfasser:	Lin, Huapeng, Yiu, Dorothy Cheuk-Yan, Chin, Simone, Liu, Ken, Yip, Terry Cheuk-Fung
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - pathology Humans Hypoglycemic Agents - therapeutic use Immunotherapy Liver Neoplasms - drug therapy Liver Neoplasms - pathology Metformin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	e182
container_issue	5
container_start_page	e180
container_title	Journal of hepatology
container_volume	78
creator	Lin, Huapeng Yiu, Dorothy Cheuk-Yan Chin, Simone Liu, Ken Yip, Terry Cheuk-Fung
description
doi_str_mv	10.1016/j.jhep.2022.12.011
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2758579183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168827822034638</els_id><sourcerecordid>2758579183</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-11c6ab11e98a50a2d76161091ee3dffc5e58e52d4f6f17b4ffe71cb3d61fd0c03</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EglL4ARYoSzYJM07ipBIbhHgJEBtYW64zpq6aB7ZTxN_jqoUl0kizOfdq5jB2hpAhoLhcZssFDRkHzjPkGSDusQkKgBREgftsEqE6rXlVH7Fj75cAkMOsOGRHuSgrnpc4YU8vFEzvWtslcQYVLHXBJ182LJJYrkKvabUaV8olWjltu75ViSNNdm27j8S27dj1YUFODd8n7MColafT3Z6y97vbt5uH9Pn1_vHm-jnVBUBIEbVQc0Sa1aoExZtKoECYIVHeGKNLKmsqeVMYYbCaF8ZQhXqeNwJNAxryKbvY9g6u_xzJB9lavzlTddSPXvKqrMtqhnUeUb5Fteu9d2Tk4Gyr3LdEkBuJcik3EuVGokQuo8QYOt_1j_OWmr_Ir7UIXG0Bil-uLTnpdfSmqbFRTZBNb__r_wFy1ISS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2758579183</pqid></control><display><type>article</type><title>Metformin in patients with hepatocellular carcinoma receiving immunotherapy</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Lin, Huapeng ; Yiu, Dorothy Cheuk-Yan ; Chin, Simone ; Liu, Ken ; Yip, Terry Cheuk-Fung</creator><creatorcontrib>Lin, Huapeng ; Yiu, Dorothy Cheuk-Yan ; Chin, Simone ; Liu, Ken ; Yip, Terry Cheuk-Fung</creatorcontrib><identifier>ISSN: 0168-8278</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2022.12.011</identifier><identifier>PMID: 36572351</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Carcinoma, Hepatocellular - drug therapy ; Carcinoma, Hepatocellular - pathology ; Humans ; Hypoglycemic Agents - therapeutic use ; Immunotherapy ; Liver Neoplasms - drug therapy ; Liver Neoplasms - pathology ; Metformin - therapeutic use</subject><ispartof>Journal of hepatology, 2023-05, Vol.78 (5), p.e180-e182</ispartof><rights>2022 European Association for the Study of the Liver</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-11c6ab11e98a50a2d76161091ee3dffc5e58e52d4f6f17b4ffe71cb3d61fd0c03</citedby><cites>FETCH-LOGICAL-c400t-11c6ab11e98a50a2d76161091ee3dffc5e58e52d4f6f17b4ffe71cb3d61fd0c03</cites><orcidid>0000-0002-1819-2464 ; 0000-0002-0453-3168</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhep.2022.12.011$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36572351$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, Huapeng</creatorcontrib><creatorcontrib>Yiu, Dorothy Cheuk-Yan</creatorcontrib><creatorcontrib>Chin, Simone</creatorcontrib><creatorcontrib>Liu, Ken</creatorcontrib><creatorcontrib>Yip, Terry Cheuk-Fung</creatorcontrib><title>Metformin in patients with hepatocellular carcinoma receiving immunotherapy</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><subject>Carcinoma, Hepatocellular - drug therapy</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Immunotherapy</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Liver Neoplasms - pathology</subject><subject>Metformin - therapeutic use</subject><issn>0168-8278</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EglL4ARYoSzYJM07ipBIbhHgJEBtYW64zpq6aB7ZTxN_jqoUl0kizOfdq5jB2hpAhoLhcZssFDRkHzjPkGSDusQkKgBREgftsEqE6rXlVH7Fj75cAkMOsOGRHuSgrnpc4YU8vFEzvWtslcQYVLHXBJ182LJJYrkKvabUaV8olWjltu75ViSNNdm27j8S27dj1YUFODd8n7MColafT3Z6y97vbt5uH9Pn1_vHm-jnVBUBIEbVQc0Sa1aoExZtKoECYIVHeGKNLKmsqeVMYYbCaF8ZQhXqeNwJNAxryKbvY9g6u_xzJB9lavzlTddSPXvKqrMtqhnUeUb5Fteu9d2Tk4Gyr3LdEkBuJcik3EuVGokQuo8QYOt_1j_OWmr_Ir7UIXG0Bil-uLTnpdfSmqbFRTZBNb__r_wFy1ISS</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Lin, Huapeng</creator><creator>Yiu, Dorothy Cheuk-Yan</creator><creator>Chin, Simone</creator><creator>Liu, Ken</creator><creator>Yip, Terry Cheuk-Fung</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1819-2464</orcidid><orcidid>https://orcid.org/0000-0002-0453-3168</orcidid></search><sort><creationdate>202305</creationdate><title>Metformin in patients with hepatocellular carcinoma receiving immunotherapy</title><author>Lin, Huapeng ; Yiu, Dorothy Cheuk-Yan ; Chin, Simone ; Liu, Ken ; Yip, Terry Cheuk-Fung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-11c6ab11e98a50a2d76161091ee3dffc5e58e52d4f6f17b4ffe71cb3d61fd0c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Carcinoma, Hepatocellular - drug therapy</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Immunotherapy</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Liver Neoplasms - pathology</topic><topic>Metformin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Huapeng</creatorcontrib><creatorcontrib>Yiu, Dorothy Cheuk-Yan</creatorcontrib><creatorcontrib>Chin, Simone</creatorcontrib><creatorcontrib>Liu, Ken</creatorcontrib><creatorcontrib>Yip, Terry Cheuk-Fung</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Huapeng</au><au>Yiu, Dorothy Cheuk-Yan</au><au>Chin, Simone</au><au>Liu, Ken</au><au>Yip, Terry Cheuk-Fung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metformin in patients with hepatocellular carcinoma receiving immunotherapy</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2023-05</date><risdate>2023</risdate><volume>78</volume><issue>5</issue><spage>e180</spage><epage>e182</epage><pages>e180-e182</pages><issn>0168-8278</issn><eissn>1600-0641</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36572351</pmid><doi>10.1016/j.jhep.2022.12.011</doi><orcidid>https://orcid.org/0000-0002-1819-2464</orcidid><orcidid>https://orcid.org/0000-0002-0453-3168</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 0168-8278
ispartof	Journal of hepatology, 2023-05, Vol.78 (5), p.e180-e182
issn	0168-8278 1600-0641
language	eng
recordid	cdi_proquest_miscellaneous_2758579183
source	MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects	Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - pathology Humans Hypoglycemic Agents - therapeutic use Immunotherapy Liver Neoplasms - drug therapy Liver Neoplasms - pathology Metformin - therapeutic use
title	Metformin in patients with hepatocellular carcinoma receiving immunotherapy
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T01%3A57%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metformin%20in%20patients%20with%20hepatocellular%20carcinoma%20receiving%20immunotherapy&rft.jtitle=Journal%20of%20hepatology&rft.au=Lin,%20Huapeng&rft.date=2023-05&rft.volume=78&rft.issue=5&rft.spage=e180&rft.epage=e182&rft.pages=e180-e182&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2022.12.011&rft_dat=%3Cproquest_cross%3E2758579183%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2758579183&rft_id=info:pmid/36572351&rft_els_id=S0168827822034638&rfr_iscdi=true